SAP picked by Moderna to help distribute COVID-19 vaccine candidate By Reuters

© Reuters. FILE PHOTO: SAP logo at SAP headquarters in Walldorf


BERLIN (Reuters) – Business software group SAP has been selected by Moderna (NASDAQ:) to help distribute the potential COVID-19 vaccine that the U.S. pharmaceuticals company is developing, CEO Christian Klein said on Monday.

“Moderna just selected SAP to help with distribution of the potential vaccine it is developing,” Klein told analysts on a conference call, discussing the development of SAP’s logistics and supply-chain business.

Moderna Inc said earlier it has started a U.S. government-backed late-stage trial for its vaccine candidate, the first to be implemented under the Trump administration’s Operation Warp Speed anti-coronavirus programme.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.